16% of 173 primary lung cancer patients demonstrated positive SALL4 expression, whereas no expression of SALL4 was observed in normal lung tissues (except for the basal layer of bronchiolar epithelium), consistent with published results by other groups [37, 40, 41]. This evidence concerns the gene SALL4 and lung carcinoma.